Clinical trial
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327 · University of Chicago, Other · Recruiting
Key facts
| NCT number | NCT00470327 |
|---|---|
| Title | A Study of the Natural Progression of Interstitial Lung Disease (ILD) |
| Official title | A Study of the Natural Progression of Interstitial Lung Disease (ILD) |
| Lead sponsor | University of Chicago, Other |
| Collaborators | Idiopathic Pulmonary Fibrosis Clinical Research Network National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Interstitial Lung Diseases, Idiopathic Pulmonary Fibrosis, Sarcoidosis, Connective Tissue Disorder |
| Enrollment | 4,000 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2030 |
| Completion | Dec 1, 2030 |
| First posted | May 7, 2007 |
| Last update posted | May 14, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: